Adult-onset opsoclonus-myoclonus-ataxia syndrome as a manifestation of brazilian lyme disease-like syndrome: a case report and review of literature

  • Angelina Maria Martins Lino Divisão de Clínica Médica do Hospital Universitário da USP
  • Raphael Ribeiro Spera Departamento de Neurologia do Hospital das Clínicas da Fac. de Medicina da USP
  • Fernando Peixoto Ferraz de Campos Divisão de Clínica Médica do Hospital Universitário da USP
  • Christian Henrique de Andrade Freitas Departamento de Neurologia do Hospital das Clínicas da Fac. de Medicina da USP
  • Márcio Ricardo Taveira Garcia Departamento de Radiologia do Instituto do Câncer do Estado de São Paulo
  • Leonardo da Costa Lopes Divisão de Clínica Médica do Hospital Universitário da USP
  • Aleksander Snioka Prokopowitsch Divisão de Clínica Médica do Hospital Universitário da USP
Keywords: Opsoclonus-Myoclonus Syndrome, Lyme Neuroborreliosis, Borrelia burgdorferi.

Abstract

Described in 1962, the opsoclonus-myoclonus-ataxia syndrome (OMAS) is a rare, neurologically debilitating disorder with distinct characteristics that may begin in childhood or adult life. Although many cases remain without etiological diagnosis, others are related to neoplasms and infectious diseases. We report a 41-year-old previously healthy male with an 8-day history of headache, vertigo, nausea, vomiting, and nystagmus. After a normal brain computed tomography and lymphocytic pleocytosis in cerebral spinal fluid (CSF), intravenous acyclovir therapy was initiated in the emergency room. On the third day of hospitalization, the diagnosis of OMAS was made based on the presence of chaotic and irregular eye movements, dysarthric speech, gait instability, generalized tremor, and myoclonic jerks. In the face of his neurological worsening, ampicillin followed by nonspecific immunotherapy (methylprednisolone and intravenous immunoglobulin) was prescribed, with mild clinical improvement. After a thorough laboratory workup, the definite diagnosis of neuroborreliosis was established and ceftriaxone (4 g/daily/3wks) and doxycycline (200 mg/day/2 mo) was administered. Toward the end of the ceftriaxone regimen, the neurologic signs substantially improved. We believe this to be the first case description of OMAS as clinical presentation of Brazilian Lyme disease-like syndrome (Baggio-Yoshinari syndrome).

Downloads

Download data is not yet available.
Published
2014-03-31
How to Cite
Lino, A., Spera, R., Campos, F., Freitas, C., Garcia, M., Lopes, L., & Prokopowitsch, A. (2014). Adult-onset opsoclonus-myoclonus-ataxia syndrome as a manifestation of brazilian lyme disease-like syndrome: a case report and review of literature. Autopsy and Case Reports, 4(1), 29-37. https://doi.org/10.4322/acr.%y.81208
Section
Article / Clinical Case Report